Polar Capital Global Healthcare Trust

Polar Capital Global Healthcare Trust (LSE: PCGH), is a large British investment trust focused on investments in the health sector. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.[1]

History

The company was established as Polar Capital Global Healthcare Growth and Income Trust in May 2010 and adopted its current name in June 2017.[2] As of August 2025, its largest investments included AstraZeneca, Eli Lilly and Company and UnitedHealth Group.[3]

In October 2025, the company asked investors to change the status of the trust from that with a limited term of eight years to one with an unlimited life, but with the opportunity for investors to exit the trust every five years.[4][5][6]

It is managed by Polar Capital and the chair is Lisa Arnold.[7]

References

  1. ^ "Diversified Energy Company (UK): Reorganisation – Update Changes in FTSE UK Index Series". FTSE Russell. 19 November 2025. Retrieved 19 November 2025.
  2. ^ "Polar Capital Global Healthcare Trust". Companies House. Retrieved 19 November 2025.
  3. ^ "The only two trusts run by Alpha Managers with top Crown ratings". Trust.net. 27 August 2025. Retrieved 19 November 2025.
  4. ^ "Top performer Polar Capital Global Healthcare looks for minimum £270m to continue after its relaunch". Quoted Data. 23 October 2025. Retrieved 19 November 2025.
  5. ^ "Healthcare sector at an inflection point: The investment case for Polar Capital Global Healthcare Trust". UK Investor Magazine. 5 November 2025. Retrieved 19 November 2025.
  6. ^ "Healthcare trusts forced to rethink discount strategies". Investors Chronicle. 18 June 2025. Retrieved 19 November 2025.
  7. ^ "Future of the Company". The Association of Investment Companies. Retrieved 19 November 2025.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.